SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-20-000051
Filing Date
2020-06-01
Accepted
2020-06-01 17:13:12
Documents
1
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159104596967197.html 4  
1 FORM 4 wf-form4_159104596967197.xml 4 9941
  Complete submission text file 0001439222-20-000051.txt   11385
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
CLARK IAN T (Reporting) CIK: 0001336504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 20934336

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations